Pacer Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-798
| Closed | -$39K | – | 1452 |
|
|
2021
Q1 | $39K | Sell |
798
-366
| -31% | -$17.9K | ﹤0.01% | 1465 |
|
|
2020
Q4 | $49K | Buy |
1,164
+262
| +29% | +$11K | ﹤0.01% | 1419 |
|
|
2020
Q3 | $41K | Buy |
+902
| New | +$41K | ﹤0.01% | 1310 |
|
|
2019
Q4 | – | Sell |
-5,170
| Closed | -$311K | – | 1261 |
|
|
2019
Q3 | $311K | Buy |
5,170
+1,234
| +31% | +$74.2K | 0.01% | 1066 |
|
|
2019
Q2 | $332K | Buy |
+3,936
| New | +$332K | 0.01% | 1021 |
|
|
2018
Q4 | – | Sell |
-2,693
| Closed | -$230K | – | 700 |
|
|
2018
Q3 | $230K | Buy |
+2,693
| New | +$230K | 0.01% | 1003 |
|
|
2018
Q1 | – | Sell |
-450
| Closed | -$26K | – | 1065 |
|
|
2017
Q4 | $26K | Buy |
+450
| New | +$26K | ﹤0.01% | 1081 |
|